Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells

NCT00003993 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT00003993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells
Lead sponsor
National Institute on Aging (NIA)
Phase
Phase 1
Overall status
Completed
Start date
September 30, 1999
Completion date
Not reported
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, small intestine cancer, unspecified adult solid tumor, protocol specific